Avantor (NYSE:AVTR) Given “Neutral” Rating at UBS Group

UBS Group restated their neutral rating on shares of Avantor (NYSE:AVTR) in a report published on Friday, MarketBeat Ratings reports. The firm currently has a $25.00 price objective on the stock, down from their previous price objective of $29.00.

A number of other brokerages have also issued reports on AVTR. Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Robert W. Baird reduced their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada reiterated an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Finally, Wells Fargo & Company cut their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $27.38.

Avantor Price Performance

Shares of Avantor stock opened at $22.14 on Friday. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor has a 52 week low of $19.59 and a 52 week high of $28.00. The stock’s 50-day simple moving average is $21.46 and its 200-day simple moving average is $23.34. The company has a market capitalization of $15.07 billion, a price-to-earnings ratio of 48.13, a PEG ratio of 3.42 and a beta of 1.28.

Institutional Investors Weigh In On Avantor

Several institutional investors have recently modified their holdings of the stock. State Street Corp raised its holdings in Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after buying an additional 8,206,695 shares during the period. 1832 Asset Management L.P. raised its stake in shares of Avantor by 1,634.9% in the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after acquiring an additional 8,038,451 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of Avantor by 653.0% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock worth $159,740,000 after acquiring an additional 5,354,678 shares during the last quarter. FMR LLC boosted its stake in shares of Avantor by 557.2% during the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after purchasing an additional 3,963,912 shares during the period. Finally, Sound Shore Management Inc. CT bought a new position in Avantor during the 2nd quarter valued at about $76,412,000. 95.08% of the stock is owned by institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.